Hsa_circ_0003489 Drives PTX Resistance of Human NSCLC Cells Through Modulating miR-98-5p/IGF2

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Barron-Barron F, Guzman-De Alba E, Alatorre-Alexander J, et al. National Clinical Practice Guidelines for the management of non-small cell lung cancer in early, locally advanced and metastatic stages. Extended version. Salud Publica Mex. 2019;61(3):359–414. doi:10.21149/9916
   PubMed Web of Science ®Google Scholar
• Cao M, Zhang L, Wang JH, et al. Identifying circRNA-associated-ceRNA networks in retinal neovascularization in mice. Int J Med Sci. 2019;16(10):1356–1365. doi:10.7150/ijms.35149
   PubMed Web of Science ®Google Scholar
• Jiang C, Xu D, You Z, Xu K, Tian W. Dysregulated circRNAs and ceRNA network in esophageal squamous cell carcinoma. Front Biosci. 2019;24(2):277–290. doi:10.2741/4717
   Google Scholar
• Zhu J, Zhang X, Gao W, Hu H, Wang X, Hao D. lncRNA/circRNAmiRNAmRNA ceRNA network in lumbar intervertebral disc degeneration. Mol Med Rep. 2019;20(4):3160–3174. doi:10.3892/mmr.2019.10569
   PubMed Web of Science ®Google Scholar
• Hong W, Xue M, Jiang J, Zhang Y, Gao X. Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC). J Exp Clin Cancer Res. 2020;39(1):149. doi:10.1186/s13046-020-01648-1
   PubMed Web of Science ®Google Scholar
• Zhang ZY, Gao XH, Ma MY, Zhao CL, Zhang YL, Guo SS. CircRNA_101237 promotes NSCLC progression via the miRNA-490-3p/MAPK1 axis. Sci Rep. 2020;10(1):9024. doi:10.1038/s41598-020-65920-2
   PubMed Web of Science ®Google Scholar
• Yang W, Wu L, Jin M. Hsa_circ_0041268 promotes NSCLC progress by sponging miR-214-5p/ROCK1. J Clin Lab Anal. 2022;36(4):e24262. doi:10.1002/jcla.24262
   PubMed Web of Science ®Google Scholar
• Du D, Cao X, Duan X, Zhang X. Blocking circ_0014130 suppressed drug resistance and malignant behaviors of docetaxel resistance-acquired NSCLC cells via regulating miR-545-3p-YAP1 axis. Cytotechnology. 2021;73(4):571–584. doi:10.1007/s10616-021-00478-z
   PubMed Web of Science ®Google Scholar
• Zhu K, Zhu J, Geng J, et al. circSNX6 (hsa_circ_0031608) enhances drug resistance of non-small cell lung cancer (NSCLC) via miR-137. Biochem Biophys Res Commun. 2021;567:79–85. doi:10.1016/j.bbrc.2021.06.032
   PubMed Web of Science ®Google Scholar
• Chen H, Li F, Xue Q. Circ-CUL2/microRNA-888-5p/RB1CC1 axis participates in cisplatin resistance in NSCLC via repressing cell advancement. Bioengineered. 2022;13(2):2828–2840. doi:10.1080/21655979.2021.2024395
   PubMed Web of Science ®Google Scholar
• Liu T, Song Z, Gai Y. Circular RNA circ_0001649 acts as a prognostic biomarker and inhibits NSCLC progression via sponging miR-331-3p and miR-338-5p. Biochem Biophys Res Commun. 2018;503(3):1503–1509. doi:10.1016/j.bbrc.2018.07.070
   PubMed Web of Science ®Google Scholar
• Shi Q, Ji T, Ma Z, Tan Q, Liang J. Serum exosomes-based biomarker circ_0008928 regulates cisplatin sensitivity, tumor progression, and glycolysis metabolism by miR-488/HK2 axis in cisplatin-resistant nonsmall cell lung carcinoma. Cancer Biother Radiopharm. 2021. doi:10.1089/cbr.2020.4490
   Web of Science ®Google Scholar
• Livingstone C. IGF2 and cancer. Endocr Relat Cancer. 2013;20(6):R321–R339. doi:10.1530/ERC-13-0231
   PubMed Web of Science ®Google Scholar
• Kasprzak A, Adamek A. Insulin-Like Growth Factor 2 (IGF2) signaling in colorectal cancer-from basic research to potential clinical applications. Int J Mol Sci. 2019;20(19):4915. doi:10.3390/ijms20194915
   PubMed Web of Science ®Google Scholar
• Luo L, Zhang Z, Qiu N, et al. Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer. Nat Commun. 2021;12(1):2699. doi:10.1038/s41467-021-23052-9
   PubMed Web of Science ®Google Scholar
• Porras-Quesada P, Gonzalez-Cabezuelo JM, Sanchez-Conde V, et al. Role of IGF2 in the study of development and evolution of prostate cancer. Front Genet. 2021;12:740641. doi:10.3389/fgene.2021.740641
   PubMed Web of Science ®Google Scholar
• Jiang W, Zhao X, Yang W. MiR-647 promotes cisplatin-induced cell apoptosis via downregulating IGF2 in non-small cell lung cancer. Minerva Med. 2021;112(2):312–313. doi:10.23736/S0026-4806.19.06240-2
   PubMed Web of Science ®Google Scholar
• Tian FQ, Chen ZR, Zhu W, et al. Inhibition of hsa_circ_0003489 shifts balance from autophagy to apoptosis and sensitizes multiple myeloma cells to bortezomib via miR-874-3p/HDAC1 axis. J Gene Med. 2021;23(9):e3329. doi:10.1002/jgm.3329
   PubMed Web of Science ®Google Scholar
• Zhan P, Shu X, Chen M, et al. miR-98-5p inhibits gastric cancer cell stemness and chemoresistance by targeting branched-chain aminotransferases 1. Life Sci. 2021;276:119405. doi:10.1016/j.lfs.2021.119405
   PubMed Web of Science ®Google Scholar
• Dong Y, Xu T, Zhong S, et al. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p. Life Sci. 2019;239:116984. doi:10.1016/j.lfs.2019.116984
   PubMed Web of Science ®Google Scholar
• Liu Y, Li C, Liu H, Wang J. Circ_0001821 knockdown suppresses growth, metastasis, and TAX resistance of non-small-cell lung cancer cells by regulating the miR-526b-5p/GRK5 axis. Pharmacol Res Perspect. 2021;9(4):e00812. doi:10.1002/prp2.812
   PubMed Web of Science ®Google Scholar
• Yu X, Fu X, Zhang X, Bai C, Wang Y. Circ_0001658 regulates gefitinib resistance of non-small cell lung cancer through miR-409-3p/TWIST1 axis. Anticancer Drugs. 2022;33(2):158–166. doi:10.1097/CAD.0000000000001257
   PubMed Web of Science ®Google Scholar
• Jiang F, Yu Q, Chu Y, et al. MicroRNA-98-5p inhibits proliferation and metastasis in non-small cell lung cancer by targeting TGFBR1. Int J Oncol. 2019;54(1):128–138. doi:10.3892/ijo.2018.4610
   PubMed Web of Science ®Google Scholar
• Wang Z, Han Z, Zhang L, Zhang S, Wang B. MicroRNA-98-5p regulates the proliferation and apoptosis of A549 cells by targeting MAP4K3. Oncol Lett. 2019;18(4):4288–4293. doi:10.3892/ol.2019.10771
   PubMed Web of Science ®Google Scholar
• Su Y, Xu C, Liu Y, Hu Y, Wu H. Circular RNA hsa_circ_0001649 inhibits hepatocellular carcinoma progression via multiple miRNAs sponge. Aging. 2019;11(10):3362–3375. doi:10.18632/aging.101988
   PubMedGoogle Scholar
• Xing S, Tian Z, Zheng W, et al. Hypoxia downregulated miR-4521 suppresses gastric carcinoma progression through regulation of IGF2 and FOXM1. Mol Cancer. 2021;20(1):9. doi:10.1186/s12943-020-01295-2
   PubMed Web of Science ®Google Scholar
• Zhuang ST, Cai YJ, Liu HP, Qin Y, Wen JF. LncRNA NEAT1/miR-185-5p/IGF2 axis regulates the invasion and migration of colon cancer. Mol Genet Genomic Med. 2020;8(4):e1125. doi:10.1002/mgg3.1125
   PubMed Web of Science ®Google Scholar
• Xue L, Tao Y, Yuan Y, Qu W, Wang W. Curcumin suppresses renal carcinoma tumorigenesis by regulating circ-FNDC3B/miR-138-5p/IGF2 axis. Anticancer Drugs. 2021;32(7):734–744. doi:10.1097/CAD.0000000000001063
   PubMed Web of Science ®Google Scholar